Canada: Pharma In Brief - Supreme Court Upholds Ban On ''Private Label'' Generic Drugs In Ontario

Case: Katz Group Canada Inc. v. Ontario (Minister of Health and Long-Term Care)
Nature of case: Appeal from applications for judicial review challenging the validity of Ontario regulations made under the ODBA and DIDFA
Successful party: Ontario (Minister of Health and Long-Term Care)
Date of decision: November 22, 2013


This was an appeal from applications for judicial review brought by Shoppers Drug Mart and Katz Group Canada Inc. ("Shoppers and Katz" or collectively the "Pharmacies"), challenging the validity of Ontario regulations made under the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10 ("ODBA") and Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23 ("DIDFA") (collectively the "Regulations"). Shoppers Drug Mart and Katz Group own and operate pharmacies across Ontario and sought to sell their own "private label" generic prescription drugs rather than source them from arms-length manufacturers. While the Divisional Court declared the impugned provisions as ultra vires, the Ontario Court of Appeal reversed this decision.

The Pharmacies were granted leave to appeal to the Supreme Court of Canada in August 2012 and sought a reversal of the Ontario Court of Appeal's decision that the impugned provisions of the Regulations banning "private label" drugs are intra vires the governing statute and of full force and effect.

The Supreme Court of Canada ("SCC") dismissed the Shoppers and Katz' appeal and upheld the Regulations as intra vires.


The ODBA is the governing legislation for Ontario's public drug benefits plan. It provides for the conditions under which the government will reimburse pharmacies for prescription drugs dispensed to eligible patients under the Ontario Drug Benefit Plan (such as seniors and persons receiving social assistance); the drugs that are reimbursed are designated as listed drug products on the Formulary. The DIDFA is the governing legislation for the dispensing and sale of prescription drugs in Ontario. The DIDFA sets out the rules surrounding generic and brand name drug interchangeability, the pricing of interchangeable drugs and the dispensing fees that may be charged by pharmacists. Generally, a generic drug cannot be sold in the "private" market unless it is designated as "interchangeable" with a brand name drug product. In 2010, several amendments were made to the ODBA and DIDFA, including a provision that banned the interchangeability and reimbursement by the provincial drug plan of "private label" drugs in Ontario.

The term "private label product" is defined in the Regulations as a drug product sold under the name of a company that: (i) is not related to the party that actually fabricates the drug; and (ii) is related to a pharmacy either through a corporate or marketing arrangement.

The Impugned Provisions

Section 12.0.2(1) of the ODBA states: A drug product that is a private label product shall not be designated as a listed drug product.

Section 9(1) of DIDFA states: A product that is a private label product shall not be designated as interchangeable.

Decisions of the Lower Courts

The Pharmacies brought an application for judicial review challenging the validity of provisions of the Regulations that prohibit the sale of "private label" generic drugs in Ontario. The practical effect of these provisions prevented the Pharmacies from selling their "private label" generics in both the public and private markets.

The Divisional Court heard two parallel applications and unanimously held that section 12.0.2 of Ontario Regulation 201/96 made under the ODBA and section 9 of Ontario Regulation 935 made under the DIDFA were ultra vires and of no force and effect. Justice Molloy declared the impugned provisions as invalid for three main reasons:

(i) the language of the provisions were prohibitory and are outside the regulation-making authority granted under the ODBA;

(ii) the provisions are extraneous to the purpose of the ODBA and DIDFA, namely to reduce the cost of prescription drugs to consumers without compromising safety; and

(iii) the provisions interfere with property and commercial rights, as limiting potential profits of a corporation are not authorized by the parent legislation.1

A summary of the Divisional Court's decision can be found here.

The Minister of Health and Long-Term Care appealed the decision of the Divisional Court. The Court of Appeal reversed the decision, holding that the regulations were intra vires and restored the impugned provisions. The Court of Appeal held that the Divisional Court erred in respect of all three reasons for invalidating the provisions. Particularly, the Divisional Court's interpretation that the impugned provisions fell outside the regulation-making authority of the ODBA and DIDFA was not warranted. Under both Acts, the Lieutenant Governor in Council is given broad regulation-making powers. Since the Regulations did not preclude the Pharmacies from participating in all aspects of the Ontario drug supply chain, they were held to be regulatory and not prohibitory.2

In a dissenting decision, Epstein J.A. upheld the decision of the Divisional Court. She held that the regulations were prohibitive and beyond the scope of the governing legislation. Moreover, the complexity, importance and cost of the regulatory scheme did not provide the government with a carte blanche.3

The decision of the Court of Appeal can be found here.

The Regulations are intra vires

The Supreme Court of Canada held that, in order for the Pharmacies to be successful in their appeal, they must be able to show that the Regulations were inconsistent with the statutory objective of the ODBA and DIDFA. The Court provides a review of the basic principles of statutory interpretation, stating that the interpretation of an enabling statute and the challenged regulations are to be given a broad and generous approach that is consistent with the Court's approach to statutory interpretation, generally, and that regulations benefit from a presumption of validity.

The overarching purpose of the enabling statutes was not in dispute. As stated by Molloy J. in the Divisional Court decision, the legislative purpose of the ODBA and DIDFA is "to control the price of prescription drugs in Ontario without compromising safety."4

Shoppers and Katz were unable to demonstrate the impugned Regulations were ultra vires. They argued that the ban on "private label" generic prescription drugs was inconsistent with the statutory purpose of the ODBA and DIDFA, and would not reduce drug prices in Ontario. The SCC rejected this argument. It was irrelevant whether the effect of the ban would prove to be successful, rather the issue was whether the provisions aligned with the purpose of the enabling statutes, which in the view of the SCC, they did.

Shoppers and Katz also argued that the impugned Regulations were ultra vires because they interfered with the commercial rights of the pharmacies. The SCC rejected this argument. The pharmaceutical supply chain is a highly regulated market where in Ontario; from a practical perspective, manufacturers cannot sell generic drugs unless they are designated as interchangeable and they cannot be reimbursed by the public drug plan unless the drug is listed on the Formulary. The SCC held that these requirements represent authorized interference with the manufacturer's ability to operate in the highly regulated market. There is no interference with the Pharmacies' commercial right.


In dismissing Shoppers and Katz' appeal, the SCC held that the provisions banning "private label drugs" fit squarely within the legislative intent of the ODBA and DIDFA. The 2010 regulatory amendments that implemented the ban on "private label" drug products were a way that the province could "prevent another possible mechanism for circumventing the ban on rebates that had kept drug prices inflated."5 The SCC reasoned that "[i]f pharmacies were permitted to create their own affiliated manufacturers whom they controlled, they would be directly involved in setting the Formulary prices and have strong incentives to keep prices high."6 Ultimately, the impugned provisions align with the purpose of the enabling statutes and the 2010 amendments, and contribute to the province's goal of lowering the price of generic drugs and providing transparent drug pricing.

In the result, Shoppers and Katz' appeal was dismissed and the impugned Regulations upheld as intra vires.

Link to decision

Katz Group Canada Inc. v. Ontario (Minister of Health and Long-Term Care), 2013 SCC 64


1 Shoppers Drug Mart Inc. et al. v. Ontario (Minister of Health and Long-Term Care), 2011 ONSC 615 at paras. 49-51, 80-81, and 85.

2 Shoppers Drug Mart Inc. et al. v. Ontario (Minister of Health and Long-Term Care), 2011 ONCA 830 at paras 47-53.

3 Ibid. at para 87.

4 Katz Group Canada Inc. v. Ontario, 2013 SCC 64 at para 32.

5 Ibid at para 34.

6 Ibid.

Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global legal practice. We provide the world's pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers based in over 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South Africa (incorporated as Deneys Reitz Inc) and Fulbright & Jaworski LLP, each of which is a separate legal entity, are members ('the Norton Rose Fulbright members') of Norton Rose Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein helps coordinate the activities of the Norton Rose Fulbright members but does not itself provide legal services to clients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.